Royalty Pharma (RPRX) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Royalty Pharma (RPRX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 23, 2024 (10:38)

Sector: Healthcare

The share price of Royalty Pharma plc (RPRX) now

Latest session on the 21st of June for
Royalty Pharma plc is positive
Trading Volume: 3209379
Open: 26.58 /  High: 26.94 /  Low: 26.46
What analysts predict: $44.33
52-week High/Low: $31.42 / $25.35

50/200 Day Moving Average: $27.62 / $28.23

This figure corresponds to the Average Price over the previous 50/200 days. For Royalty Pharma stocks, the 50-day moving average is the resistance level today.

For Royalty Pharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Royalty Pharma plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Royalty Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one Royalty Pharma share be worth in 2024 - 2028?

When should I take profit in Royalty Pharma stock? When should I record a loss on Royalty Pharma stock? What are analysts' forecasts for Royalty Pharma stock? What is the future of Royalty Pharma stock? We forecast Royalty Pharma stock performance using neural networks based on historical data on Royalty Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Royalty Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Royalty Pharma shares. This happens once a day.


Historical and forecast chart of Royalty Pharma stock

The chart below shows the historical price of Royalty Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Royalty Pharma stock price can be found in the table below.

Long-term forecasts by years.

Royalty Pharma plc is a biopharmaceutical royalty purchaser and innovation sponsor for the US biopharmaceutical industry. He is also involved in identifying, evaluating and obtaining royalties for various biopharmaceuticals. In addition, the company partners with innovators from academic institutions, research hospitals and non-profit organizations, small and medium-sized biotech companies, and pharmaceutical companies.

Royalty Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 25 27.46 27.11 27.65 2.01
Jun 26 27.20 26.61 27.56 3.56
Jun 27 26.73 26.44 26.97 2.00
Jun 28 26.03 25.71 26.39 2.61
Jun 29 26.17 25.72 26.61 3.45
Jun 30 26.80 26.48 27.00 1.94
Jul 01 26.47 26.22 26.91 2.63
Jul 02 26.39 25.97 26.66 2.65
Jul 03 25.96 25.72 26.54 3.21
Jul 04 25.37 25.07 25.55 1.91
Jul 05 24.94 24.41 25.26 3.49
Jul 06 24.70 24.46 24.95 1.97
Jul 07 24.72 24.57 25.10 2.17
Jul 08 25.15 24.79 25.41 2.50
Jul 09 25.30 24.97 25.86 3.56
Jul 10 25.93 25.31 26.43 4.43
Jul 11 26.54 26.02 27.16 4.41
Jul 12 26.49 25.89 26.79 3.47
Jul 13 25.87 25.56 26.20 2.49
Jul 14 26.25 25.86 26.52 2.56
Jul 15 26.32 26.06 26.82 2.91
Jul 16 26.18 25.84 26.50 2.58
Jul 17 25.79 25.53 26.13 2.36
Jul 18 26.03 25.77 26.56 3.06
Jul 19 26.35 26.03 26.67 2.49
Jul 20 25.99 25.37 26.24 3.41
Jul 21 26.10 25.58 26.57 3.89
Jul 22 26.10 25.91 26.45 2.09
Jul 23 26.03 25.85 26.29 1.69
Jul 24 25.25 24.91 25.42 2.04

Royalty Pharma Daily Price Targets


Royalty Pharma Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $27.46.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 1.966%.
Pessimistic target level: 27.11
Optimistic target level: 27.65

Royalty Pharma Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $27.20.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 3.435%.
Pessimistic target level: 26.61
Optimistic target level: 27.56

Royalty Pharma Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $26.73.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 1.962%.
Pessimistic target level: 26.44
Optimistic target level: 26.97

Royalty Pharma Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $26.03.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 2.546%.
Pessimistic target level: 25.71
Optimistic target level: 26.39

Royalty Pharma Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $26.17.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 3.334%.
Pessimistic target level: 25.72
Optimistic target level: 26.61

Royalty Pharma Stock Forecast 06-30-2024.

Forecast target price for 06-30-2024: $26.80.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 1.906%.
Pessimistic target level: 26.48
Optimistic target level: 27.00

RPRX (RPRX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 26.39 25.76 27.16 5.17
Aug. 26.57 25.20 27.86 9.55
Sep. 25.72 24.28 26.38 7.98
Oct. 24.28 23.78 25.28 5.92
Nov. 23.68 22.47 24.20 7.13
Dec. 25.01 23.98 26.04 7.93

Royalty Pharma forecast for this year


Royalty Pharma Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $26.3877. Pessimistic: $25.76. Optimistic: $27.16


Royalty Pharma Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $26.5724. Pessimistic: $25.20. Optimistic: $27.86


Royalty Pharma Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $25.7167. Pessimistic: $24.28. Optimistic: $26.38


Royalty Pharma Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $24.2766. Pessimistic: $23.78. Optimistic: $25.28


Royalty Pharma Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $23.6818. Pessimistic: $22.47. Optimistic: $24.20


Royalty Pharma Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $25.008. Pessimistic: $23.98. Optimistic: $26.04



Royalty Pharma (RPRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 26.50 25.75 27.37 5.90
Feb 25.87 24.56 27.19 9.66
Mar 25.18 23.87 26.46 9.79
Apr 25.46 24.25 26.74 9.33
May 23.86 23.27 24.59 5.36
Jun 24.69 24.07 25.54 5.75
Jul 25.85 25.34 27.26 7.04
Aug 26.61 25.75 28.01 8.05
Sep 27.71 26.45 28.29 6.51
Oct 29.18 28.10 29.86 5.88
Nov 29.88 28.83 30.46 5.35
Dec 30.19 29.30 31.50 6.98

Royalty Pharma (RPRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 30.21 29.64 31.78 6.72
Feb 30.65 29.17 31.56 7.55
Mar 31.53 30.52 32.31 5.53
Apr 31.00 30.35 31.87 4.77
May 31.35 30.78 33.11 7.03
Jun 32.54 32.06 33.70 4.87
Jul 32.13 31.65 33.05 4.22
Aug 32.24 30.98 34.02 8.95
Sep 33.07 31.99 34.67 7.75
Oct 32.22 31.59 33.01 4.30
Nov 30.01 29.38 31.52 6.80
Dec 29.73 28.55 31.09 8.17

Royalty Pharma (RPRX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 30.38 28.74 31.00 7.27
Feb 30.72 29.86 32.10 6.97
Mar 31.75 31.06 32.35 3.98
Apr 32.62 31.00 33.19 6.60
May 34.58 33.57 35.38 5.13
Jun 34.10 33.36 35.10 4.96
Jul 35.36 34.84 36.53 4.61
Aug 36.82 35.46 37.42 5.24
Sep 37.60 35.60 38.55 7.65
Oct 38.57 37.03 39.27 5.71
Nov 39.54 38.16 41.20 7.39
Dec 39.46 38.77 41.26 6.03

Royalty Pharma (RPRX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 39.54 38.63 40.71 5.10
Feb 41.54 39.68 42.67 7.02
Mar 41.16 40.09 42.05 4.66
Apr 41.62 39.35 43.43 9.39
May 42.06 41.03 44.41 7.62
Jun 43.56 42.73 44.90 4.82
Jul 45.48 44.68 47.36 5.65
Aug 46.34 44.42 47.34 6.17
Sep 49.22 47.54 50.81 6.44
Oct 47.12 45.21 49.07 7.87
Nov 46.60 44.31 47.67 7.05
Dec 45.13 43.45 46.93 7.40

Royalty Pharma information and performance

Royalty Pharma Address

110 EAST 59TH STREET, NEW YORK, NY, US

Market Capitalization: 15 909 747 000 $

Market capitalization of the Royalty Pharma plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RPRX shares in the company outstanding by the market price of one share.

EBITDA: 1 497 820 000 $

EBITDA of Royalty Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: 14.96

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.176

Price/earnings to growth

DPS: 0.81

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0316

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.78

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.986
Quarterly Revenue Growth YOY: -0.17
Trailing PE: 14.96

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 8.31

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 7.44

Enterprise Value (EV) /Revenue

EV To EBITDA: 9.28

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 452110000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Royalty Pharma (RPRX) stock dividend

Royalty Pharma last paid dividends on 05/16/2024. The next scheduled payment will be on 06/14/2024. The amount of dividends is $0.81 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.